Abnormal nuclear envelopes in the striatum and motor deficits in DYT11 myoclonus-dystonia mouse models

Human Molecular Genetics

Volumn 21, Issue 4, 2012, Pages 916-925

  Yokoi, Fumiaki ^a   Dang, Mai T ^b   Zhou, Tong ^c   Li, Yuqing ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^c University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPSILON SARCOGLYCAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BALANCE IMPAIRMENT; CELL NUCLEUS MEMBRANE; CONTROLLED STUDY; CORPUS STRIATUM; FEMALE; KNOCKOUT MOUSE; LEARNING DISORDER; LOCOMOTION; MALE; MOTOR COORDINATION; MOTOR DYSFUNCTION; MYOCLONUS DYSTONIA; NERVE CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; ROTAROD TEST; WALKING;

ANIMALS; DISEASE MODELS, ANIMAL; DYSTONIC DISORDERS; FEMALE; LOCOMOTION; MALE; MICE; MICE, KNOCKOUT; NEOSTRIATUM; NUCLEAR ENVELOPE; PHENOTYPE; PSYCHOMOTOR DISORDERS; SARCOGLYCANS;

MUS;

EID: 84863011117     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddr528     Document Type: Article

References (64)

1. Fahn, S. (1988) Concept and classification of dystonia. Adv. Neurol., 50, 1-8.
2. Breakefield, X.O., Blood, A.J., Li, Y., Hallett, M., Hanson, P.I. and Standaert, D.G. (2008) The pathophysiological basis of dystonias. Nat. Rev. Neurosci., 9, 222-234.
3. Camargos, S., Scholz, S., Simon-Sanchez, J., Paisan-Ruiz, C., Lewis, P., Hernandez, D., Ding, J., Gibbs, J.R., Cookson, M.R., Bras, J. et al. (2008) DYT16, a novel young-onset dystonia-parkinsonism disorder: identification of a segregating mutation in the stress-response protein PRKRA. Lancet Neurol., 7, 207-215.
4. Fuchs, T., Gavarini, S., Saunders-Pullman, R., Raymond, D., Ehrlich, M.E., Bressman, S.B. and Ozelius, L.J. (2009) Mutations in the THAP1 gene are responsible for DYT6 primary torsion dystonia. Nat. Genet., 41, 286-288.
5. Caviness, J.N. and Brown, P. (2004) Myoclonus: current concepts and recent advances. Lancet Neurol., 3, 598-607.
6. Kinugawa, K., Vidailhet, M., Clot, F., Apartis, E., Grabli, D. and Roze, E. (2009) Myoclonus-dystonia: an update. Mov. Disord., 24, 479-489.
7. Valente, E.M., Misbahuddin, A., Brancati, F., Placzek, M.R., Garavaglia, B., Salvi, S., Nemeth, A., Shaw-Smith, C., Nardocci, N., Bentivoglio, A.R. et al. (2003) Analysis of the epsilon-sarcoglycan gene in familial and sporadic myoclonus-dystonia: evidence for genetic heterogeneity. Mov. Disord., 18, 1047-1051.
8. Han, F., Racacho, L., Lang, A.E., Bulman, D.E. and Grimes, D.A. (2007) Refinement of the DYT15 locus in myoclonus dystonia. Mov. Disord., 22, 888-892.
9. Zimprich, A., Grabowski, M., Asmus, F., Naumann, M., Berg, D., Bertram, M., Scheidtmann, K., Kern, P., Winkelmann, J., Muller-Myhsok, B. et al. (2001) Mutations in the gene encoding epsilon-sarcoglycan cause myoclonus-dystonia syndrome. Nat. Genet., 29, 66-69.
10. Sandona, D. and Betto, R. (2009) Sarcoglycanopathies: molecular pathogenesis and therapeutic prospects. Expert Rev. Mol. Med., 11, e28.
11. Ozawa, E., Noguchi, S., Mizuno, Y., Hagiwara, Y. and Yoshida, M. (1998) From dystrophinopathy to sarcoglycanopathy: evolution of a concept of muscular dystrophy. Muscle Nerve, 21, 421-438.
12. Laval, S.H. and Bushby, K.M. (2004) Limb-girdle muscular dystrophies-from genetics to molecular pathology. Neuropathol. Appl. Neurobiol., 30, 91-105.
13. Wheeler, M.T., Zarnegar, S. and McNally, E.M. (2002) Zeta-sarcoglycan, a novel component of the sarcoglycan complex, is reduced in muscular dystrophy. Hum. Mol. Genet., 11, 2147-2154.
14. Ettinger, A.J., Feng, G. and Sanes, J.R. (1997) epsilon-Sarcoglycan, a broadly expressed homologue of the gene mutated in limb-girdle muscular dystrophy 2D. J. Biol. Chem., 272, 32534-32538.
15. Ettinger, A.J., Feng, G. and Sanes, J.R. (1998) Additions and Corrections to epsilon-Sarcoglycan, a broadly expressed homologue of the gene mutated in limb-girdle muscular dystrophy 2D. J. Biol. Chem., 273, 19922.
16. Nishiyama, A., Endo, T., Takeda, S. and Imamura, M. (2004) Identification and characterization of epsilon-sarcoglycans in the central nervous system. Brain Res. Mol. Brain Res., 125, 1-12.
17. Yokoi, F., Dang, M.T., Mitsui, S. and Li, Y. (2005) Exclusive paternal expression and novel alternatively spliced variants of epsilon-sarcoglycan mRNA in mouse brain. FEBS Lett., 579, 4822-4828.
18. McNally, E.M., Ly, C.T. and Kunkel, L.M. (1998) Human epsilon-sarcoglycan is highly related to alpha-sarcoglycan (adhalin), the limb girdle muscular dystrophy 2D gene. FEBS Lett., 422, 27-32.
19. Ritz, K., van Schaik, B.D., Jakobs, M.E., van Kampen, A.H., Aronica, E., Tijssen, M.A. and Baas, F. (2011) SGCE isoform characterization and expression in human brain: implications for myoclonus-dystonia pathogenesis? Eur. J. Hum. Genet., 19, 438-444.
20. Xiao, J. and LeDoux, M.S. (2003) Cloning, developmental regulation and neural localization of rat epsilon-sarcoglycan. Brain Res. Mol. Brain Res., 119, 132-143.
21. Dickens, N.J., Beatson, S. and Ponting, C.P. (2002) Cadherin-like domains in alpha-dystroglycan, alpha/epsilon-sarcoglycan and yeast and bacterial proteins. Curr. Biol., 12, R197-R199.
22. Sheng, M. and Sala, C. (2001) PDZ domains and the organization of supramolecular complexes. Annu. Rev. Neurosci., 24, 1-29.
23. Shiga, K., Yoshioka, H., Matsumiya, T., Kimura, I., Takeda, S. and Imamura, M. (2006) Zeta-sarcoglycan is a functional homologue of gamma-sarcoglycan in the formation of the sarcoglycan complex. Exp. Cell Res., 312, 2083-2092.
24. Grabowski, M., Zimprich, A., Lorenz-Depiereux, B., Kalscheuer, V., Asmus, F., Gasser, T., Meitinger, T. and Strom, T.M. (2003) The epsilon-sarcoglycan gene (SGCE), mutated in myoclonus-dystonia syndrome, is maternally imprinted. Eur. J. Hum. Genet., 11, 138-144.
25. Piras, G., El Kharroubi, A., Kozlov, S., Escalante-Alcalde, D., Hernandez, L., Copeland, N.G., Gilbert, D.J., Jenkins, N.A. and Stewart, C.L. (2000) Zac1 (Lot1), a potential tumor suppressor gene, and the gene for epsilon-sarcoglycan are maternally imprinted genes: identification by a subtractive screen of novel uniparental fibroblast lines. Mol. Cell Biol., 20, 3308-3315.
26. Muller, B., Hedrich, K., Kock, N., Dragasevic, N., Svetel, M., Garrels, J., Landt, O., Nitschke, M., Pramstaller, P.P., Reik, W. et al. (2002) Evidence that paternal expression of the epsilon-sarcoglycan gene accounts for reduced penetrance in myoclonus-dystonia. Am. J. Hum. Genet., 71, 1303-1311.
27. Lancioni, A., Luisa Rotundo, I., Monique Kobayashi, Y., D'Orsi, L., Aurino, S., Nigro, G., Piluso, G., Acampora, D., Cacciottolo, M., Campbell, K.P. et al. (2011) Combined deficiency of alpha and epsilon sarcoglycan disrupts the cardiac dystrophin complex. Hum. Mol. Genet., 20, 4644-4654.
28. Hedrich, K., Meyer, E.M., Schule, B., Kock, N., de Carvalho Aguiar, P., Wiegers, K., Koelman, J.H., Garrels, J., Durr, R., Liu, L. et al. (2004) Myoclonus-dystonia: detection of novel, recurrent, and de novo SGCE mutations. Neurology, 62, 1229-1231.
29. Yokoi, F., Dang, M.T., Li, J. and Li, Y. (2006) Myoclonus, motor deficits, alterations in emotional responses and monoamine metabolism in epsilon-sarcoglycan deficient mice. J. Biochem., 140, 141-146.
30. Carbon, M., Kingsley, P.B., Su, S., Smith, G.S., Spetsieris, P., Bressman, S. and Eidelberg, D. (2004) Microstructural white matter changes in carriers of the DYT1 gene mutation. Ann. Neurol., 56, 283-286.
31. Yokoi, F., Dang, M.T., Miller, C.A., Marshall, A.G., Campbell, S.L., Sweatt, J.D. and Li, Y. (2009) Increased c-fos expression in the central nucleus of the amygdala and enhancement of cued fear memory in Dyt1 DeltaGAG knock-in mice. Neurosci. Res., 65, 228-235.
32. Naismith, T.V., Heuser, J.E., Breakefield, X.O. and Hanson, P.I. (2004) TorsinA in the nuclear envelope. Proc. Natl Acad. Sci. USA, 101, 7612-7617.
33. Gonzalez-Alegre, P. and Paulson, H.L. (2004) Aberrant cellular behavior of mutant torsinA implicates nuclear envelope dysfunction in DYT1 dystonia. J. Neurosci., 24, 2593-2601.
34. Goodchild, R.E. and Dauer, W.T. (2004) Mislocalization to the nuclear envelope: an effect of the dystonia-causing torsinA mutation. Proc. Natl Acad. Sci. USA, 101, 847-852.
35. Nery, F.C., Zeng, J., Niland, B.P., Hewett, J., Farley, J., Irimia, D., Li, Y., Wiche, G., Sonnenberg, A. and Breakefield, X.O. (2008) TorsinA binds the KASH domain of nesprins and participates in linkage between nuclear envelope and cytoskeleton. J. Cell Sci., 121, 3476-3486.
36. Goodchild, R.E., Kim, C.E. and Dauer, W.T. (2005) Loss of the dystonia-associated protein torsinA selectively disrupts the neuronal nuclear envelope. Neuron, 48, 923-932.
37. Grundmann, K., Reischmann, B., Vanhoutte, G., Hubener, J., Teismann, P., Hauser, T.K., Bonin, M., Wilbertz, J., Horn, S., Nguyen, H.P. et al. (2007) Overexpression of human wildtype torsinA and human DeltaGAG torsinA in a transgenic mouse model causes phenotypic abnormalities. Neurobiol. Dis., 27, 190-206.
38. Yokoi, F., Dang, M.T., Li, J., Standaert, D.G. and Li, Y. (2011) Motor deficits and decreased striatal dopamine receptor 2 binding activity in the striatum-specific Dyt1 conditional knockout mice. PLoS ONE, 6, e24539.
39. Kim, C.E., Perez, A., Perkins, G., Ellisman, M.H. and Dauer, W.T. (2010) A molecular mechanism underlying the neural-specific defect in torsinA mutant mice. Proc. Natl Acad. Sci. USA, 107, 9861-9866.
40. Tolosa, E. and Compta, Y. (2006) Dystonia in Parkinson's disease. J. Neurol., 253(Suppl. 7), VII7-VII13.
41. Abdo, W.F., van de Warrenburg, B.P., Burn, D.J., Quinn, N.P. and Bloem, B.R. (2010) The clinical approach to movement disorders. Nat. Rev. Neurol., 6, 29-37.
42. Braak, H., Ghebremedhin, E., Rub, U., Bratzke, H. and Del Tredici, K. (2004) Stages in the development of Parkinson's disease-related pathology. Cell Tissue Res., 318, 121-134.
43. Shoulson, I. and Young, A.B. (2011) Milestones in huntington disease. Mov. Disord., 26, 1127-1133.
44. Segawa, M. (2009) Autosomal dominant GTP cyclohydrolase I (AD GCH 1) deficiency (Segawa disease, dystonia 5; DYT 5). Chang Gung Med. J., 32, 1-11.
45. Augood, S.J., Hollingsworth, Z., Albers, D.S., Yang, L., Leung, J.C., Muller, B., Klein, C., Breakefield, X.O. and Standaert, D.G. (2002) Dopamine transmission in DYT1 dystonia: a biochemical and autoradiographical study. Neurology, 59, 445-448.
46. Dang, M.T., Yokoi, F., McNaught, K.S., Jengelley, T.A., Jackson, T., Li, J. and Li, Y. (2005) Generation and Characterization of Dyt1 deltaGAG Knock-in Mouse as a Model for Early-Onset Dystonia. Exp. Neurol., 196, 452-463.
47. Dang, M.T., Yokoi, F., Pence, M.A. and Li, Y. (2006) Motor deficits and hyperactivity in Dyt1 knockdown mice. Neurosci. Res., 56, 470-474.
48. Napolitano, F., Pasqualetti, M., Usiello, A., Santini, E., Pacini, G., Sciamanna, G., Errico, F., Tassone, A., Di Dato, V., Martella, G. et al. (2010) Dopamine D2 receptor dysfunction is rescued by adenosine A2A receptor antagonism in a model of DYT1 dystonia. Neurobiol. Dis., 38, 434-445.
49. Beukers, R.J., Booij, J., Weisscher, N., Zijlstra, F., van Amelsvoort, T.A. and Tijssen, M.A. (2009) Reduced striatal D2 receptor binding in myoclonus-dystonia. Eur. J. Nucl. Med. Mol. Imaging, 36, 269-274.
50. Yokoi, F., Yang, G., Li, J., Deandrade, M.P., Zhou, T. and Li, Y. (2010) Earlier onset of motor deficits in mice with double mutations in Dyt1 and Sgce. J. Biochem., 148, 459-466.
51. Sauer, B. and Henderson, N. (1988) Site-specific DNA recombination in mammalian cells by the Cre recombinase of bacteriophage P1. Proc. Natl Acad. Sci. USA, 85, 5166-5170.
52. Schwenk, F., Baron, U. and Rajewsky, K. (1995) A cre-transgenic mouse strain for the ubiquitous deletion of loxP-flanked gene segments including deletion in germ cells. Nucleic Acids Res., 23, 5080-5081.
53. Dang, M.T., Yokoi, F., Yin, H.H., Lovinger, D.M., Wang, Y. and Li, Y. (2006) Disrupted motor learning and long-term synaptic plasticity in mice lacking NMDAR1 in the striatum. Proc. Natl Acad. Sci. USA, 103, 15254-15259.
54. Fernagut, P., Diguet, E., Stefanova, N., Biran, M., Wenning, G., Canioni, P., Bioulac, B. and Tison, F. (2002) Subacute systemic 3-nitropropionic acid intoxication induces a distinct motor disorder in adult C57Bl/6 mice: behavioural and histopathological characterisation. Neuroscience, 114, 1005.
55. DeAndrade, M.P., Yokoi, F., van Groen, T., Lingrel, J.B. and Li, Y. (2011) Characterization of Atp1a3 mutant mice as a model of rapid-onset dystonia with parkinsonism. Behav. Brain Res., 216, 659-665.
56. Nagano, A. and Arahata, K. (2000) Nuclear envelope proteins and associated diseases. Curr. Opin. Neurol., 13, 533-539.
57. Meunier, S., Lourenco, G., Roze, E., Apartis, E., Trocello, J.M. and Vidailhet, M. (2008) Cortical excitability in DYT-11 positive myoclonus dystonia. Mov. Disord., 23, 761-764.
58. Li, J.Y., Cunic, D.I., Paradiso, G., Gunraj, C., Pal, P.K., Lang, A.E. and Chen, R. (2008) Electrophysiological features of myoclonus-dystonia. Mov. Disord., 23, 2055-2061.
59. Roze, E., Apartis, E., Clot, F., Dorison, N., Thobois, S., Guyant-Marechal, L., Tranchant, C., Damier, P., Doummar, D., Bahi-Buisson, N. et al. (2008) Myoclonus-dystonia: clinical and electrophysiologic pattern related to SGCE mutations. Neurology, 70, 1010-1016.
60. van der Salm, S.M., van Rootselaar, A.F., Foncke, E.M., Koelman, J.H., Bour, L.J., Bhatia, K.P., Rothwell, J.C. and Tijssen, M.A. (2009) Normal cortical excitability in Myoclonus-Dystonia-a TMS study. Exp. Neurol., 216, 300-305.
61. Farley, F.W., Soriano, P., Steffen, L.S. and Dymecki, S.M. (2000) Widespread recombinase expression using FLPeR (flipper) mice. Genesis, 28, 106-110.
62. Campos, V.E., Du, M. and Li, Y. (2004) Increased seizure susceptibility and cortical malformation in beta-catenin mutant mice. Biochem. Biophys. Res. Commun., 320, 606-614.
63. Cao, B.J. and Li, Y. (2002) Reduced anxiety- and depression-like behaviors in Emx1 homozygous mutant mice. Brain Res., 937, 32-40.
64. Yokoi, F., Dang, M.T., Mitsui, S., Li, J. and Li, Y. (2008) Motor deficits and hyperactivity in cerebral cortex-specific Dyt1 conditional knockout mice. J. Biochem., 143, 39-47.